Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00717769 · ClinicalTrials.gov registry record · Phase 2
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Phase 2 study, sponsored by Daiichi Sankyo.
- Completed
- Registry status
- Phase 2
- Development phase
- 270
- Enrollment target
NCT00717769 is a Phase 2 study that has completed, run by Daiichi Sankyo. The registered enrollment target is 270 participants.
The verdict
NCT00717769, a Phase 2 study, has completed, sponsored by Daiichi Sankyo.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 270 participants
- Enrollment target
Study Summary
The purpose of the study is to explore the efficacy and safety of SUN13834 vs placebo in adult participants with atopic dermatitis.
Interventions
- DRUG Placebo
- DRUG SUN13834
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2008-07-16 |
| Est. Completion | 2009-04-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00717769
The ClinicalTrials.gov registry entry for NCT00717769 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Daiichi Sankyo, which has 236 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00717769 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00717769 about?
NCT00717769 is a clinical study titled "A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis". The purpose of the study is to explore the efficacy and safety of SUN13834 vs placebo in adult participants with atopic dermatitis.
What is the current status of trial NCT00717769?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 270 participants. The study started on 2008-07-16. Estimated completion is 2009-04-09.
What interventions are being tested in trial NCT00717769?
The interventions under investigation include: Placebo (DRUG), SUN13834 (DRUG).
Who is sponsoring clinical trial NCT00717769?
This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.